🇺🇸 FDA
Patent

US 11560428

CD33-binding polypeptides and uses thereof

granted A61KA61K45/06A61K47/55

Quick answer

US patent 11560428 (CD33-binding polypeptides and uses thereof) held by Inhibrx, Inc. expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K45/06, A61K47/55, A61P, A61P35/00